Tech Company Financing Transactions

Qvella Funding Round

Qvella closed a $20 million Series B investment round on 12/5/2017. Investors included RA Capital, Whitecap Venture Partners and Hatteras Venture Partners.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

9133 Leslie St. 110
Richmond Hill ON, L4B 4N1
Canada

Phone

(289) 317-0407

Website

www.qvella.com

Email Address

Not Recorded

Overview

Qvella is a molecular diagnostics company with the goal of dramatically reducing time to results in bacteriology. The company has developed a highly differentiated technology for pathogen detection by direct sampling of boldily fluids without the need for culturing or time consuming sample processing.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Tino Alavie

        

Chief Scientific Officer

Samad Talebpour

        

VP - Bus. Development

Glenn Magnuson

        

VP - Marketing

Stephen Clark

        

VP - Product Management

Robert Maaskant

        

VP - Regulatory Affairs

Susan Novak-Weekley

        

Browse more venture capital transactions:

Prev: 12/5/2017: Pacejet Logistics venture capital transaction
Next: 12/5/2017: Noodle Partners venture capital transaction

Share this article

Where The Data Comes From

We report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary